3-(Benzo[d]oxazol-2-yl)-2-(N-3-morpholino-4-ylpropyl)aminoquinoxaline

ID: ALA4558870

PubChem CID: 155557654

Max Phase: Preclinical

Molecular Formula: C22H23N5O2

Molecular Weight: 389.46

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  c1ccc2nc(-c3nc4ccccc4o3)c(NCCCN3CCOCC3)nc2c1

Standard InChI:  InChI=1S/C22H23N5O2/c1-2-7-17-16(6-1)24-20(22-26-18-8-3-4-9-19(18)29-22)21(25-17)23-10-5-11-27-12-14-28-15-13-27/h1-4,6-9H,5,10-15H2,(H,23,25)

Standard InChI Key:  CVWUBASFVMPIHG-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   30.0654  -16.8597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0643  -17.6792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7723  -18.0882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7706  -16.4508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4792  -16.8561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4799  -17.6751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1885  -18.0822    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.8967  -17.6713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8920  -16.8492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1829  -16.4459    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.5972  -16.4363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6060  -18.0772    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.3121  -17.6658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3431  -16.7659    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.6750  -15.6249    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.4732  -15.4500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8835  -16.1532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6958  -16.1486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0988  -15.4414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6835  -14.7375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8726  -14.7457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0214  -18.0717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7275  -17.6603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4368  -18.0662    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.4362  -18.8874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1415  -19.2932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8500  -18.8853    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.8488  -18.0672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1390  -17.6569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  9 11  1  0
  8 12  1  0
 12 13  1  0
 11 14  2  0
 14 17  1  0
 16 15  1  0
 15 11  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 13 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4558870

    ---

Associated Targets(Human)

WI-38 (2654 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MGC-803 (6426 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T-24 (2342 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 389.46Molecular Weight (Monoisotopic): 389.1852AlogP: 3.57#Rotatable Bonds: 6
Polar Surface Area: 76.31Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.11CX LogP: 2.98CX LogD: 2.80
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.51Np Likeness Score: -1.35

References

1. Liu QQ, Lu K, Zhu HM, Kong SL, Yuan JM, Zhang GH, Chen NY, Gu CX, Pan CX, Mo DL, Su GF..  (2019)  Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.,  165  [PMID:30685528] [10.1016/j.ejmech.2019.01.004]

Source